OBJECTIVE: To study the infectious background of patients with a history of acute anterior uveitis (AAU) and healthy control subjects. METHODS: Sixty four patients with previous AAU and 64 sex and age matched controls were studied. Serum antibodies to Salmonellae, Yersiniae, Klebsiella pneumoniae, Escherichia coli, Proteus mirabilis, Campylobacter jejuni, and Borrelia burgdorferi were measured using enzyme linked immunosorbent assay (ELISA), and antibodies to Chlamydia trachomatis and Chlamydia pneumoniae by microimmunofluorescence test. Peripheral blood mononuclear cells (PBMCs), separated by density gradient centrifugation, were studied for Salmonella and Yersinia antigens by means of an immunofluorescence test, and for C pneumoniae DNA with a polymerase chain reaction (PCR). RESULTS: Neither prevalence nor levels of single microbial antibodies studied differed between the patients and control subjects, or between subgroups of patients created on the basis of clinical characteristics. In logistic regression analysis, the high number of recurrences (>10) of AAU was independently related to the presence of single or multiple bacterial antibodies (p=0.04). None of the PBMC samples of the patients were positive for Yersinia or Salmonella antigens. C pneumoniae PCR was positive in a patient who was negative for C pneumoniae antibodies. CONCLUSION: Although neither the prevalence nor the levels of single microbial antibodies studied differed between the patients and the controls, current data suggest that the presence of single or multiple antibodies in patients with many recurrences of AAU compared with patients with none or few recurrences may be a sign of repeated infections, antigen persistence, or raised innate immune responsiveness.
OBJECTIVE: To study the infectious background of patients with a history of acute anterior uveitis (AAU) and healthy control subjects. METHODS: Sixty four patients with previous AAU and 64 sex and age matched controls were studied. Serum antibodies to Salmonellae, Yersiniae, Klebsiella pneumoniae, Escherichia coli, Proteus mirabilis, Campylobacter jejuni, and Borrelia burgdorferi were measured using enzyme linked immunosorbent assay (ELISA), and antibodies to Chlamydia trachomatis and Chlamydia pneumoniae by microimmunofluorescence test. Peripheral blood mononuclear cells (PBMCs), separated by density gradient centrifugation, were studied for Salmonella and Yersinia antigens by means of an immunofluorescence test, and for C pneumoniae DNA with a polymerase chain reaction (PCR). RESULTS: Neither prevalence nor levels of single microbial antibodies studied differed between the patients and control subjects, or between subgroups of patients created on the basis of clinical characteristics. In logistic regression analysis, the high number of recurrences (>10) of AAU was independently related to the presence of single or multiple bacterial antibodies (p=0.04). None of the PBMC samples of the patients were positive for Yersinia or Salmonella antigens. C pneumoniae PCR was positive in a patient who was negative for C pneumoniae antibodies. CONCLUSION: Although neither the prevalence nor the levels of single microbial antibodies studied differed between the patients and the controls, current data suggest that the presence of single or multiple antibodies in patients with many recurrences of AAU compared with patients with none or few recurrences may be a sign of repeated infections, antigen persistence, or raised innate immune responsiveness.
Authors: M Huhtinen; M Puolakkainen; K Laasila; M Sarvas; A Karma; M Leirisalo-Repo Journal: Invest Ophthalmol Vis Sci Date: 2001-07 Impact factor: 4.799
Authors: M Huhtinen; H Repo; K Laasila; S-E Jansson; H Kautiainen; A Karma; M Leirisalo-Repo Journal: Br J Ophthalmol Date: 2002-04 Impact factor: 4.638
Authors: M van der Paardt; J C van Denderen; A J van den Brule; S A Morré; I E van der Horst-Bruinsma; P D Bezemer; B A Dijkmans Journal: Ann Rheum Dis Date: 2000-04 Impact factor: 19.103
Authors: M Leirisalo; G Skylv; M Kousa; L M Voipio-Pulkki; H Suoranta; M Nissilä; L Hvidman; E D Nielsen; A Svejgaard; A Tilikainen; O Laitinen Journal: Arthritis Rheum Date: 1982-03
Authors: K Granfors; S Jalkanen; R von Essen; R Lahesmaa-Rantala; O Isomäki; K Pekkola-Heino; R Merilahti-Palo; R Saario; H Isomäki; A Toivanen Journal: N Engl J Med Date: 1989-01-26 Impact factor: 91.245
Authors: Xiwen Ji; Zicheng Zhang; Dan Lin; Mali Dai; Xia Zhao; Xingneng Guo; Jie Du; Meng Zhou; Yuqin Wang Journal: Transl Vis Sci Technol Date: 2021-11-01 Impact factor: 3.283
Authors: Maren Kasper; Karoline Walscheid; Björn Laffer; Dirk Bauer; Martin Busch; Lena Wildschütz; Bo Wang; Karin Loser; Thomas Vogl; Rafael S Grajewski; Thomas Langmann; Arnd Heiligenhaus Journal: Front Immunol Date: 2018-07-30 Impact factor: 7.561